Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
Delayed Nasdaq  -  04:00 2022-08-05 pm EDT
186.84 USD   -3.78%
02:09aClimate change puts Lyme disease in focus for France's Valneva after COVID blow
RE
08/05PUMP / DUMP #40 : This week's gainers and losers
MS
08/05U.S. administers over 7,300 Novavax vaccine doses - CDC
RE
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Insider Sell: Moderna

06/27/2022 | 05:17pm EDT
share with twitter
share with LinkedIn
share with facebook


© MT Newswires 2022
All news about MODERNA, INC.
02:09aClimate change puts Lyme disease in focus for France's Valneva after COVID blow
RE
08/05PUMP / DUMP #40 : This week's gainers and losers
MS
08/05U.S. administers over 7,300 Novavax vaccine doses - CDC
RE
08/04Goldman Sachs Raises Moderna's Price Target to $296 From $290, Maintains Buy Rating
MT
08/04Morgan Stanley Adjusts Moderna's Price Target to $197 From $199, Maintains Equalweight ..
MT
08/04SVB Securities Adjusts Moderna's Price Target to $74 from $77, Keeps Underperform Ratin..
MT
08/04MARKETSCREENER'S WORLD PRESS REVIEW : August 4, 2022
MS
08/04Moderna Reiterates $21 Billion COVID-19 Vaccine Sales Forecast On Expected New Approval..
MT
08/03US Stocks Advance on Surprise Increase in Service Activity, Rise in Factory Orders
MT
08/03Nasdaq ends at three-month high as PayPal fuels optimism
RE
More news
Analyst Recommendations on MODERNA, INC.
More recommendations
Financials (USD)
Sales 2022 21 875 M - -
Net income 2022 11 063 M - -
Net cash 2022 17 049 M - -
P/E ratio 2022 7,03x
Yield 2022 -
Capitalization 73 092 M 73 092 M -
EV / Sales 2022 2,56x
EV / Sales 2023 5,16x
Nbr of Employees 2 700
Free-Float 92,1%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Last Close Price 186,84 $
Average target price 214,00 $
Spread / Average Target 14,5%
EPS Revisions
Managers and Directors
Stéphane Bancel Chief Executive Officer & Director
Stephen Hoge President
David W. Meline Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capi. (M$)
MODERNA, INC.-26.44%73 092
IQVIA HOLDINGS INC.-16.80%43 781
LONZA GROUP AG-26.44%43 083
SEAGEN INC.13.72%32 426
ALNYLAM PHARMACEUTICALS, INC.28.89%26 235
CELLTRION, INC.-0.51%20 815